These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals. Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020 [TBL] [Abstract][Full Text] [Related]
8. Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. Bourboulia D; Aldam D; Lagos D; Allen E; Williams I; Cornforth D; Copas A; Boshoff C AIDS; 2004 Feb; 18(3):485-93. PubMed ID: 15090801 [TBL] [Abstract][Full Text] [Related]
10. The host control of lytic and latent infection with human herpesvirus-8. Stebbing J; Gazzard B; Bower M J Infect Dis; 2006 Apr; 193(8):1051-3. PubMed ID: 16544244 [No Abstract] [Full Text] [Related]
11. The sex ratio of AIDS-associated Kaposi's sarcoma does not provide evidence that sex hormones play a role in pathogenesis. Grulich AE; Kaldor JM AIDS; 1996 Nov; 10(13):1595-6. PubMed ID: 8931798 [No Abstract] [Full Text] [Related]
12. Kaposi's sarcoma in pregnancy after initiation of highly active antiretroviral therapy: a manifestation of immune reconstitution syndrome. Adeyemo A; Wood C; Govind A Int J STD AIDS; 2012 Dec; 23(12):905-6. PubMed ID: 23258835 [TBL] [Abstract][Full Text] [Related]
13. Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity. Yarchoan R; Pluda JM; Wyvill KM; Aleman K; Rodriguez-Chavez IR; Tosato G; Catanzaro AT; Steinberg SM; Little RF Crit Rev Immunol; 2007; 27(5):401-14. PubMed ID: 18197804 [TBL] [Abstract][Full Text] [Related]
14. Histological features of kaposi sarcoma in a patient receiving highly active antiviral therapy. Eng W; Cockerell CJ Am J Dermatopathol; 2004 Apr; 26(2):127-32. PubMed ID: 15024195 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. Quinlivan EB; Wang RX; Stewart PW; Kolmoltri C; Regamey N; Erb P; Vernazza PL; J Med Virol; 2001 Jun; 64(2):157-66. PubMed ID: 11360248 [TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma and protection from HIV dementia. Liestael K; Goplen AK; Dunlop O; Bruun JN; Maehlen J Science; 1998 Apr; 280(5362):361-2. PubMed ID: 9575077 [No Abstract] [Full Text] [Related]